Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Semaglutide on the Inflammatory Response and Clinical Course of Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus

NCT06475586 is registered in ClinicalTrials.gov with University of Banja Luka as lead sponsor.

NCT NCT06475586
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06475586 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Semaglutide on the Inflammatory Response and Clinical Course of Psoriatic Lesions in Patients With Type 2 Diabetes Mellitus
Lead sponsor
University of Banja Luka
Phase
Phase 4
Overall status
Completed
Start date
May 3, 2023
Completion date
June 10, 2024
Enrollment
30 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

diabetes type 2, psoriasis vulgaris